Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200419876> ?p ?o ?g. }
- W4200419876 endingPage "174695" @default.
- W4200419876 startingPage "174695" @default.
- W4200419876 abstract "Alzheimer's disease (AD) is one of the leading causes of dependence and disability among the elderly worldwide. The traditional anti-Alzheimer medication, rivastigmine, one of the cholinesterase inhibitors (ChEIs), fails to achieve a definitive cure. We tested the hypothesis that naproxen administration to the rivastigmine-treated aluminum chloride (AlCl3) Alzheimer's rat model could provide an additive neuroprotective effect compared to rivastigmine alone.The studied groups were control (Cont), AlCl3 treated (Al), rivastigmine treated (RIVA), naproxen treated (Napro), and combined rivastigmine and naproxen treated (RIVA + Napro). Rats' memory, spatial learning, and cognitive behavior were assessed followed by evaluation of hippocampal acetylcholinesterase (AChE) activity. Hippocampal and cerebellar histopathology were thoroughly examined. Activated caspase-3 and the neuroepithelial stem cells marker; nestin expressions were immunohistochemically assayed.AD rats displayed significantly impaired memory and cognitive function, augmented hippocampal AChE activity; massive neurodegeneration associated with enhanced astrogliosis, apoptosis, and impaired neurogenesis. Except for the enhancement of neurogenesis and suppression of apoptosis, the combination therapy had no additional neuroprotective benefit over rivastigmine-only therapy.Naproxen's efficacy was established by its ability to function at the cellular level, improved neurogenesis, and decreased, apoptosis without having an additional mitigating impact on cognitive impairment in rivastigmine-treated AD rats." @default.
- W4200419876 created "2021-12-31" @default.
- W4200419876 creator A5007159503 @default.
- W4200419876 creator A5040367481 @default.
- W4200419876 creator A5047459994 @default.
- W4200419876 creator A5071118963 @default.
- W4200419876 date "2022-01-01" @default.
- W4200419876 modified "2023-10-17" @default.
- W4200419876 title "Naproxen as a potential candidate for promoting rivastigmine anti-Alzheimer activity against aluminum chloride-prompted Alzheimer's-like disease in rats; neurogenesis and apoptosis modulation as a possible underlying mechanism" @default.
- W4200419876 cites W1485747833 @default.
- W4200419876 cites W1516122098 @default.
- W4200419876 cites W1528960277 @default.
- W4200419876 cites W1607135210 @default.
- W4200419876 cites W1609153296 @default.
- W4200419876 cites W1678111194 @default.
- W4200419876 cites W1735388412 @default.
- W4200419876 cites W1794343535 @default.
- W4200419876 cites W1861730929 @default.
- W4200419876 cites W1890121728 @default.
- W4200419876 cites W1903439745 @default.
- W4200419876 cites W1935951477 @default.
- W4200419876 cites W1966687534 @default.
- W4200419876 cites W1967674023 @default.
- W4200419876 cites W1967709670 @default.
- W4200419876 cites W1968001587 @default.
- W4200419876 cites W1969027460 @default.
- W4200419876 cites W1969305530 @default.
- W4200419876 cites W1970156306 @default.
- W4200419876 cites W1970626421 @default.
- W4200419876 cites W1972094490 @default.
- W4200419876 cites W1972960028 @default.
- W4200419876 cites W1973827313 @default.
- W4200419876 cites W1977051019 @default.
- W4200419876 cites W1977162415 @default.
- W4200419876 cites W1981546185 @default.
- W4200419876 cites W1982064952 @default.
- W4200419876 cites W1982918443 @default.
- W4200419876 cites W1982994872 @default.
- W4200419876 cites W1985187905 @default.
- W4200419876 cites W1986229796 @default.
- W4200419876 cites W1987188463 @default.
- W4200419876 cites W1989780177 @default.
- W4200419876 cites W1991794361 @default.
- W4200419876 cites W1993280146 @default.
- W4200419876 cites W1996419973 @default.
- W4200419876 cites W1996557575 @default.
- W4200419876 cites W1998140650 @default.
- W4200419876 cites W1998778991 @default.
- W4200419876 cites W1999348374 @default.
- W4200419876 cites W2002544384 @default.
- W4200419876 cites W2003944592 @default.
- W4200419876 cites W2003966687 @default.
- W4200419876 cites W2008254819 @default.
- W4200419876 cites W2008354106 @default.
- W4200419876 cites W2011418880 @default.
- W4200419876 cites W2011746987 @default.
- W4200419876 cites W2013165583 @default.
- W4200419876 cites W2014335053 @default.
- W4200419876 cites W2016429852 @default.
- W4200419876 cites W2018708829 @default.
- W4200419876 cites W2022320253 @default.
- W4200419876 cites W2022536210 @default.
- W4200419876 cites W2024452593 @default.
- W4200419876 cites W2024979365 @default.
- W4200419876 cites W2025192037 @default.
- W4200419876 cites W2026286016 @default.
- W4200419876 cites W2026410063 @default.
- W4200419876 cites W2026930283 @default.
- W4200419876 cites W2027944706 @default.
- W4200419876 cites W2028540464 @default.
- W4200419876 cites W2028638859 @default.
- W4200419876 cites W2033354781 @default.
- W4200419876 cites W2038967600 @default.
- W4200419876 cites W2039490668 @default.
- W4200419876 cites W2042754407 @default.
- W4200419876 cites W2044975042 @default.
- W4200419876 cites W2045560271 @default.
- W4200419876 cites W2045637271 @default.
- W4200419876 cites W2045981464 @default.
- W4200419876 cites W2046030136 @default.
- W4200419876 cites W2047058073 @default.
- W4200419876 cites W2047667409 @default.
- W4200419876 cites W2047704857 @default.
- W4200419876 cites W2048510554 @default.
- W4200419876 cites W2048712314 @default.
- W4200419876 cites W2049011501 @default.
- W4200419876 cites W2049734627 @default.
- W4200419876 cites W2051615377 @default.
- W4200419876 cites W2051999371 @default.
- W4200419876 cites W2052943568 @default.
- W4200419876 cites W2055092854 @default.
- W4200419876 cites W2055558890 @default.
- W4200419876 cites W2055676865 @default.
- W4200419876 cites W2057249855 @default.
- W4200419876 cites W2057608998 @default.
- W4200419876 cites W2058238349 @default.
- W4200419876 cites W2058876174 @default.
- W4200419876 cites W2060467019 @default.